Skip to content
Fear & Greed51 Neutral
Crypto market$2.72T+0.60%24h breadth151 up92 downBitcoin$80,608+0.67%Ethereum$2,331+0.33%Solana$101+0.58%XRP$1.31+0.15%BNB$749+0.83%Top gainersBTW$1.76+26.00%PONS$0.289+17.39%BLUR$0.0085+15.55%Top losersOSMO$0.052−11.95%REZ$0.0048−9.48%NIL$0.083−9.20%StocksNVDA$218−0.17%TSLA$398−2.21%AAPL$345−0.58%MSFT$530−0.26%COIN$158−1.61%
Advertisement
Bristol Myers Squibb buys Nvidia’s latest AI computing system for drug research

Bristol Myers Squibb buys Nvidia’s latest AI computing system for drug research

The pharma giant is the first life sciences company to deploy Nvidia's Vera Rubin-based DGX SuperPOD, boosting its computing power more than tenfold

by Editorial Team

2 min read

In Technology

Share

Add us on Google

NVIDIA Corporation (NVDA) price

Full chart and stats

Loading chart…

Market cap
$5.3T (shares as of 2026-08-21)
P/E (trailing)
27.6 (EPS to 2026-07-26)
Annual revenue
$215.9B USD (FY ended 2026-01-25) 10-K
Annual revenue growth
+65.5% (FY ended 2026-01-25 vs FY ended 2025-01-26) 10-K
Annual net income
120,067,000,000 USD (FY ended 2026-01-25, attributable to the company) 10-K
Annual operating margin
60.4% (FY ended 2026-01-25)
Forward P/E
Unavailable: no dated forecast source

Gloria daily close for session Oct 27, 2026. Market cap and trailing P/E use this close with the SEC share total and trailing diluted earnings, each dated next to its figure. Annual revenue, revenue growth, net income and margin show their own fiscal period and link the 10-K. Current context may postdate this article.

NVIDIA Corporation and its peers

Company PriceMarket capP/E (trailing)Forward P/EAnnual revenue (USD)Annual revenue growthAnnual net income (USD)Operating margin
NVIDIA Corporation NVDA · Price dated Oct 27, 2026 · tokenized NVDAx $218$5.3T27.6Unavailable$215.9BFY ended 2026-01-25 · 10-K+65.5%FY ended 2026-01-25 vs 2025-01-26 · 10-K120,067,000,000FY ended 2026-01-25, attributable to the company · 10-K60.4%FY ended 2026-01-25
Broadcom Inc. AVGO · Price dated Oct 27, 2026 · tokenized AVGOx $342$1.6T43.7Unavailable$63.9BFY ended 2025-11-02 · 10-K+23.9%FY ended 2025-11-02 vs 2024-11-03 · 10-K23,126,000,000FY ended 2025-11-02, consolidated · 10-K39.9%FY ended 2025-11-02
Micron Technology Inc. MU · Price dated Oct 27, 2026 · tokenized MUx $929$1.1T12.5Unavailable$133.2BFY ended 2026-09-03 · 10-K+256.3%FY ended 2026-09-03 vs 2025-08-28 · 10-K84,969,000,000FY ended 2026-09-03, attributable to the company · 10-K74.6%FY ended 2026-09-03
Advanced Micro Devices Inc. AMD · Price dated Oct 27, 2026 · tokenized AMDx $560$914.6B143.7Unavailable$34.6BFY ended 2025-12-27 · 10-K+34.3%FY ended 2025-12-27 vs 2024-12-28 · 10-K4,335,000,000FY ended 2025-12-27, attributable to the company · 10-K10.7%FY ended 2025-12-27

Missing figures stay unavailable. Forward P/E requires a dated source. Annual revenue, revenue growth, net income and margin come from each company's own 10-K, in US dollars, and each row shows that fiscal year. Revenue growth compares the fiscal year with the prior year stated in the same 10-K. Net income is the full year amount attributable to the company, or available to common stockholders where the filing states only that, or consolidated net income. Each row names its basis. Trailing P/E reads "Not meaningful" when the dated trailing diluted EPS is a loss or zero. An operating margin appears only when the filing states both the operating income and the revenue for the same year.

Sources: SEC filings, Gloria daily closes and CoinGecko. Oldest record refresh: Oct 27, 2026, 9:41 PM EDT. Refresh is not a price or filing date. Each row shows its price date and its annual fiscal period. Peers use industry code and company size, or editorial selection. Market cap multiplies that row price by the company share total the latest SEC filing states for every share class together. Trailing P/E divides it by trailing diluted earnings from SEC filings. Rolled earnings per share are approximate because share counts can change between periods. Both appear only when the SEC data carries its date, so they are estimates at one price date, not synchronized filing valuations. Not investment advice.

Token vs underlying stock

Current comparison for NVDA. Historical observations may postdate this article.

NVDAx token unit vs NVDA share · USD

$218.06Oct 27 UTC

+2.7% over displayed period

● NVDAx token┄ NVDA stock: $217.94

Aug 4, 2026: token $212.33 at 20:00 UTC; stock close $211.94 Aug 5, 2026: token $219.87 at 20:00 UTC; stock close $219.22 Aug 6, 2026: token $219.15 at 20:00 UTC; stock close $218.99 Aug 7, 2026: token $223.93 at 20:00 UTC; stock close $223.96 Aug 10, 2026: token $217.66 at 20:00 UTC; stock close $217.55 Aug 11, 2026: token $217.53 at 20:00 UTC; stock close $217.50 Aug 12, 2026: token $224.12 at 20:00 UTC; stock close $224.09 Aug 13, 2026: token $225.42 at 20:00 UTC; stock close $225.30 Aug 14, 2026: token $225.34 at 20:00 UTC; stock close $225.16 Aug 17, 2026: token $225.13 at 20:00 UTC; stock close $225.01 Aug 18, 2026: token $219.70 at 20:00 UTC; stock close $219.74 Aug 19, 2026: token $217.76 at 20:00 UTC; stock close $217.56 Aug 20, 2026: token $216.79 at 20:00 UTC; stock close $216.85 Aug 21, 2026: token $214.85 at 20:00 UTC; stock close $214.72 Aug 24, 2026: token $208.75 at 20:00 UTC; stock close $208.48 Aug 25, 2026: token $213.16 at 20:00 UTC; stock close $213.05 Aug 26, 2026: token $210.06 at 20:00 UTC; stock close $209.66 Aug 27, 2026: token $227.96 at 20:00 UTC; stock close $227.98 Aug 28, 2026: token $217.74 at 20:00 UTC; stock close $217.55 Aug 31, 2026: token $220.91 at 20:00 UTC; stock close $220.78 Sep 1, 2026: token $217.58 at 20:00 UTC; stock close $217.44 Sep 2, 2026: token $224.46 at 20:00 UTC; stock close $224.41 Sep 3, 2026: token $228.90 at 20:00 UTC; stock close $228.45 Sep 4, 2026: token $230.35 at 20:00 UTC; stock close $230.36 Sep 8, 2026: token $225.69 at 20:00 UTC; stock close $225.73 Sep 9, 2026: token $223.89 at 20:00 UTC; stock close $223.67 Sep 10, 2026: token $218.70 at 20:00 UTC; stock close $218.36 Sep 11, 2026: token $218.92 at 20:00 UTC; stock close $218.29 Sep 14, 2026: token $211.47 at 20:00 UTC; stock close $210.96 Sep 15, 2026: token $212.34 at 20:00 UTC; stock close $212.17 Sep 16, 2026: token $214.25 at 20:00 UTC; stock close $213.90 Sep 17, 2026: token $219.68 at 20:00 UTC; stock close $219.34 Sep 18, 2026: token $222.24 at 20:00 UTC; stock close $222.27 Sep 21, 2026: token $227.69 at 20:00 UTC; stock close $227.38 Sep 22, 2026: token $229.20 at 20:00 UTC; stock close $228.87 Sep 23, 2026: token $225.44 at 20:00 UTC; stock close $225.51 Sep 24, 2026: token $224.87 at 20:00 UTC; stock close $224.58 Sep 25, 2026: token $225.29 at 20:00 UTC; stock close $225.07 Sep 28, 2026: token $228.97 at 20:00 UTC; stock close $228.86 Sep 29, 2026: token $227.95 at 20:00 UTC; stock close $227.21 Sep 30, 2026: token $229.85 at 20:00 UTC; stock close $228.38 Oct 1, 2026: token $231.18 at 20:00 UTC; stock close $230.86 Oct 2, 2026: token $234.38 at 20:00 UTC; stock close $233.95 Oct 5, 2026: token $239.30 at 20:00 UTC; stock close $238.90 Oct 6, 2026: token $239.71 at 20:00 UTC; stock close $239.24 Oct 7, 2026: token $237.80 at 20:00 UTC; stock close $237.47 Oct 8, 2026: token $230.81 at 20:00 UTC; stock close $230.48 Oct 9, 2026: token $229.70 at 20:00 UTC; stock close $229.28 Oct 12, 2026: token $226.87 at 20:00 UTC; stock close $226.32 Oct 13, 2026: token $228.73 at 20:00 UTC; stock close $228.52 Oct 14, 2026: token $221.56 at 20:00 UTC; stock close $221.30 Oct 15, 2026: token $217.48 at 20:00 UTC; stock close $217.23 Oct 16, 2026: token $214.56 at 20:00 UTC; stock close $214.13 Oct 19, 2026: token $217.41 at 20:00 UTC; stock close $217.09 Oct 20, 2026: token $216.69 at 20:00 UTC; stock close $216.47 Oct 21, 2026: token $222.20 at 20:00 UTC; stock close $221.97 Oct 22, 2026: token $212.42 at 20:00 UTC; stock close $212.21 Oct 23, 2026: token $211.27 at 20:00 UTC; stock close $210.96 Oct 26, 2026: token $216.15 at 20:00 UTC; stock close $216.00 Oct 27, 2026: token $218.06 at 20:00 UTC; stock close $217.94
Aug 4$208.48 to $239.71Oct 27

Source: CoinGecko + Gloria · Retrieved Oct 28, 13:15 UTC

Methodology and data

Split-adjusted regular-session stock closes from the existing Gloria shared history, paired only with an observed token price within 45 minutes of 16:00 New York time. Up to 60 matched sessions. No interpolation or missing-date fill. Weekends and known early closes are omitted. Token units are not adjusted for issuer multipliers or dividend treatment. This compares quoted prices, not fair value, executable premiums or arbitrage returns. Solid line: token. Dashed line: stock. Exact quote times and values appear below. Historical observations. Retrieval refers to the token source. Token quote times use UTC. The fixed cohort shows its oldest member fetch.

Nvidia token vs Nvidia stock: exact source values
Date (UTC)Token (USD)Stock close (USD)Token quote (UTC)
2026-08-04212.33211.942026-08-04 20:00
2026-08-05219.87219.222026-08-05 20:00
2026-08-06219.15218.992026-08-06 20:00
2026-08-07223.93223.962026-08-07 20:00
2026-08-10217.66217.552026-08-10 20:00
2026-08-11217.53217.502026-08-11 20:00
2026-08-12224.12224.092026-08-12 20:00
2026-08-13225.42225.302026-08-13 20:00
2026-08-14225.34225.162026-08-14 20:00
2026-08-17225.13225.012026-08-17 20:00
2026-08-18219.70219.742026-08-18 20:00
2026-08-19217.76217.562026-08-19 20:00
2026-08-20216.79216.852026-08-20 20:00
2026-08-21214.85214.722026-08-21 20:00
2026-08-24208.75208.482026-08-24 20:00
2026-08-25213.16213.052026-08-25 20:00
2026-08-26210.06209.662026-08-26 20:00
2026-08-27227.96227.982026-08-27 20:00
2026-08-28217.74217.552026-08-28 20:00
2026-08-31220.91220.782026-08-31 20:00
2026-09-01217.58217.442026-09-01 20:00
2026-09-02224.46224.412026-09-02 20:00
2026-09-03228.90228.452026-09-03 20:00
2026-09-04230.35230.362026-09-04 20:00
2026-09-08225.69225.732026-09-08 20:00
2026-09-09223.89223.672026-09-09 20:00
2026-09-10218.70218.362026-09-10 20:00
2026-09-11218.92218.292026-09-11 20:00
2026-09-14211.47210.962026-09-14 20:00
2026-09-15212.34212.172026-09-15 20:00
2026-09-16214.25213.902026-09-16 20:00
2026-09-17219.68219.342026-09-17 20:00
2026-09-18222.24222.272026-09-18 20:00
2026-09-21227.69227.382026-09-21 20:00
2026-09-22229.20228.872026-09-22 20:00
2026-09-23225.44225.512026-09-23 20:00
2026-09-24224.87224.582026-09-24 20:00
2026-09-25225.29225.072026-09-25 20:00
2026-09-28228.97228.862026-09-28 20:00
2026-09-29227.95227.212026-09-29 20:00
2026-09-30229.85228.382026-09-30 20:00
2026-10-01231.18230.862026-10-01 20:00
2026-10-02234.38233.952026-10-02 20:00
2026-10-05239.30238.902026-10-05 20:00
2026-10-06239.71239.242026-10-06 20:00
2026-10-07237.80237.472026-10-07 20:00
2026-10-08230.81230.482026-10-08 20:00
2026-10-09229.70229.282026-10-09 20:00
2026-10-12226.87226.322026-10-12 20:00
2026-10-13228.73228.522026-10-13 20:00
2026-10-14221.56221.302026-10-14 20:00
2026-10-15217.48217.232026-10-15 20:00
2026-10-16214.56214.132026-10-16 20:00
2026-10-19217.41217.092026-10-19 20:00
2026-10-20216.69216.472026-10-20 20:00
2026-10-21222.20221.972026-10-21 20:00
2026-10-22212.42212.212026-10-22 20:00
2026-10-23211.27210.962026-10-23 20:00
2026-10-26216.15216.002026-10-26 20:00
2026-10-27218.06217.942026-10-27 20:00

Stock history: Gloria · Retrieved Oct 28, 00:31 UTC. Token history: CoinGecko NVDAx.

Quoted token and share units can have different rights, multipliers and dividend treatment. This is not an executable premium or arbitrage signal.

Bristol Myers Squibb just became the first pharmaceutical company to get its hands on Nvidia’s latest-generation AI supercomputer. The company announced on July 20 that it has acquired a DGX SuperPOD built on Nvidia’s Vera Rubin architecture, a system it plans to aim squarely at the notoriously slow and expensive process of discovering new drugs.

What BMS actually bought

The new deployment consists of eight DGX Vera Rubin NVL72 systems, packaged together as a single DGX SuperPOD. BMS says it represents more than a tenfold increase in computing capacity compared to the AI infrastructure it installed around 2023. BMS claims this is now the most powerful and energy-efficient Nvidia infrastructure operating anywhere in life sciences.

Advertisement

The deal also gives BMS access to Nvidia’s BioNeMo platform and Agent Toolkit. These tools let the pharma giant train its own proprietary foundation models and build agentic AI workflows — essentially autonomous AI agents that can run complex drug discovery tasks with minimal human involvement.

BMS and Nvidia have been collaborating for roughly three years. The earlier DGX SuperPOD deployment already proved its worth by cutting AI-enabled target identification times from weeks to dramatically shorter windows. BMS also reported a 55% reduction in computing costs for certain workloads during that initial phase.

The broader AI infrastructure arms race

Drug discovery is one of the most compute-hungry problems in science. Simulating how a molecule interacts with a protein target, screening billions of potential compounds, predicting toxicity profiles: these tasks demand exactly the kind of parallel processing that GPU clusters excel at. Traditional drug development takes an average of over a decade and costs billions per approved therapy.

BMS clearly believes the math works. The 55% cost reduction it achieved with the previous, less powerful system suggests the return on investment scales favorably as compute power increases.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.